Modifying the cellular transport of DNA-based vaccines alters the immune response to hantavirus nucleocapsid protein

被引:19
作者
Bucht, G [1 ]
Sjölander, KB
Eriksson, S
Lindgren, L
Lundkvist, Å
Elgh, F
机构
[1] Swedish Def Res Agcy, Div NBC Def, Dept Med Countermeasures, SE-90182 Umea, Sweden
[2] Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17182 Solna, Sweden
[3] Swedish Inst Infect Dis Control, Dept Virol, SE-17182 Solna, Sweden
[4] Ctr Microbiol Preparedness, SE-17182 Solna, Sweden
[5] Umea Univ, Dept Virol, SE-90185 Umea, Sweden
关键词
cellular transport; DNA vaccines; hantavirus; immune response; Puumala virus;
D O I
10.1016/S0264-410X(01)00151-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Puumala virus is a member of the hantavirus genus (family Bunyaviridae) and is one of the causative agents of hemorrhagic fever with renal syndrome (HFRS in Europe. A genetic vaccination approach was conducted to investigate if the immune response could be modulated using different cellular secretion and/or localisation signals, and the immune responses were analysed in BALB/c mice and in a bank vole infectious model. Rodents vaccinated with DNA constructs encoding the antigen fused to an amino-terminal secretion signal raised significantly higher antibody levels when compared to using constructs lacking secretion signals. Furthermore, the ratios of the IgG subclasses (IgG2a/IgG1) were raised by the use of cellular localisation signals, indicating a more pronounced Th1-type of immune response. The majority of the mice, or bank voles, immunised with DNA encoding a secreted form of the antigen showed a positive lymphoproliferative response and were protected against challenge with Puumala virus (strain Kazan-wt). (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3820 / 3829
页数:10
相关论文
共 40 条
[1]   Serologic evidence of Puumala virus infection in wild moose in northern Sweden [J].
Ahlm, C ;
Wallin, K ;
Lundkvist, Å ;
Elgh, F ;
Juto, P ;
Merza, M ;
Tärnvik, A .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2000, 62 (01) :106-111
[2]   REMOVAL OF ENDOTOXIN FROM PROTEIN SOLUTIONS BY PHASE-SEPARATION USING TRITON X-114 [J].
AIDA, Y ;
PABST, MJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 132 (02) :191-195
[3]   Cell surface display and intracellular trafficking of free glycosylphosphatidylinositols in mammalian cells [J].
Baumann, NA ;
Vidugiriene, J ;
Machamer, CE ;
Menon, AK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) :7378-7389
[4]   Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB c mice [J].
Bharadwaj, M ;
Lyons, CR ;
Wortman, IA ;
Hjelle, B .
VACCINE, 1999, 17 (22) :2836-2843
[5]   Optimising the signal peptide for glycosyl phosphatidylinositol modification of human acetylcholinesterase using mutational analysis and peptide-quantitative structure-activity relationships [J].
Bucht, G ;
Wikström, P ;
Hjalmarsson, K .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1999, 1431 (02) :471-482
[6]   ELECTROPORATION FOR THE EFFICIENT TRANSFECTION OF MAMMALIAN-CELLS WITH DNA [J].
CHU, G ;
HAYAKAWA, H ;
BERG, P .
NUCLEIC ACIDS RESEARCH, 1987, 15 (03) :1311-1326
[7]   COMPARISON OF THE KINETICS OF PUUMALA VIRUS-SPECIFIC IGM AND IGG ANTIBODY-RESPONSES IN NEPHROPATHIA-EPIDEMICA AS MEASURED BY A RECOMBINANT ANTIGEN-BASED ENZYME-LINKED-IMMUNOSORBENT-ASSAY AND AN IMMUNOFLUORESCENCE TEST [J].
ELGH, F ;
WADELL, G ;
JUTO, P .
JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (02) :146-150
[8]  
Elgh F, 1998, FEMS IMMUNOL MED MIC, V22, P309
[9]   Genetic vaccines: Strategies for optimization [J].
Gregoriadis, G .
PHARMACEUTICAL RESEARCH, 1998, 15 (05) :661-670
[10]   Comparative study of DNA-based immunization vectors: Effect of secretion signals on the antibody responses in mice [J].
Haddad, D ;
Liljeqvist, S ;
Stahl, S ;
Andersson, I ;
Perlmann, P ;
Berzins, K ;
Ahlborg, N .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1997, 18 (03) :193-202